Progress in Neuro-Psychopharmacology and Biological Psychiatry
Glucocorticoids, cytokines and brain abnormalities in depression
Introduction
Major depression (MD) is one of the most common psychiatric disorders in the Western World, and according to the World Health Organization it is predicted to be the leading cause of burden of disease by 2030 (WHO report 2004). Only a third of patients receive adequate treatment and up to half of them relapse despite the increasing number of antidepressant drugs currently available (Thase, 2006). This reflects the heterogeneity of the disorder, which has a complex and multifactorial aetiology originating from the interaction between environmental and genetic factors and presents frequent co-morbidity. Several theories have been proposed to explain its pathogenesis, including the monoamine hypothesis, based on deficiency of the biogenic amine system (particularly serotonin and norepinephrine) (Charney, 1998, Hirschfeld, 2000), the hypothalamic-pituitary-adrenal (HPA) axis dysfunction theory, based on hyperactivity of this system usually reflected in high levels of glucocorticoids (Dinan, 1994, Pariante and Lightman, 2008), cognitive and behavioural theories (Beck et al., 1979, Harmer et al., 2009), the neurogenesis hypothesis (Jacobs et al., 2005, Duman, 2004, Kempermann and Kronenberg, 2003, Sahay and Hen, 2007, Kempermann et al., 2008, Zhao et al., 2008), the inflammatory theory, also known as the malaise or cytokine theory (Smith, 1991, Ur et al., 1992, Maes et al., 2009, Miller et al., 2009), and the neurodegenerative hypothesis (Myint and Kim, 2003, Maes et al., 2009). With the aim to better understand the pathophysiology of depression, these hypotheses, which indeed have some biological features in common, are being drawn together. Specifically, the last two models, reviewed in this special issue on ‘Neuro-inflammatory and Neuro-degenerative Pathways in Major Depression’, are gaining more relevance. Most interesting is the role of glucocorticoids not only in the HPA axis dysfunction model but also in the two models stated above. Are glucocorticoids a potential link between inflammation and degeneration? The answer to this question is not clear.
Glucocorticoids, released by the adrenal gland in response to stress, are among the most potent anti-inflammatory hormones in the body (Vinson, 2009). Some studies have suggested that they contribute to the hippocampal atrophy found in depressed patients (Sapolsky, 2000, McEwen, 2005). The involvement of stress in the development of depressive symptomatology may involve several systems, including the neuroendocrine, the neurotransmitter and the immune systems, that interact with the HPA axis in complex ways (Baune, 2009). However, to date, the role of the above-mentioned systems in the pathogenesis of depression is contradictory and subject to differing interpretations. In this review we will focus the attention on glucocorticoids and inflammation processes, trying to summarize and clarify as best as we can their involvement in MD, and to understand whether they have a direct cause in the abnormalities observed in the brain of depressed patients.
Section snippets
The HPA axis in major depression
One of the characteristic features of MD that has been found over the past years is the disturbance in the HPA functionality (Pariante, 2003, Pariante, 2006). HPA axis activity is governed by the secretion of corticotrophin releasing hormone (CRH) and arginine–vasopressin (AVP) from the hypothalamus, which in turn activate the secretion of adrenocorticotrophin hormone (ACTH) from the pituitary. ACTH then stimulates the secretion of glucocorticoids (cortisol in humans and corticosterone in
Inflammation and depression
As stated in the Introduction, the current theories on serotonergic dysfunctions and cortisol hypersecretion, on their own, do not provide sufficient explanations for the nature of depression. Since depression is a complex disorder, it is likely that alterations in several systems, which interact and interplay in concert, underlie the pathogenesis of the disease. The evidence that cytokine-mediated inflammatory processes play an important role in the development of depression is now strong.
Interactions between cytokines and glucocorticoids: what comes first?
Is it possible to know if cytokines directly cause disturbances of the HPA axis and GR downregulation? Or do they maybe enhance a disturbance that was already caused by a previous stressor? Glucocorticoid resistance can underlie the HPA axis disturbances and this might be caused by cytokines. Since communication occurs between the endocrine, immune, and central nervous system, an activation of the inflammatory responses can affect neuroendocrine processes, and vice versa. In fact, stress can
Neurodegeneration
Several brain regions, specially the hippocampus, undergo structural changes in depression (Sheline, 2003). In particular, neuroimaging studies have consistently shown reduced size of hippocampal volume in MD as reported by meta-analysis studies of patients with recurrent depression (Videbech and Ravnkilde, 2004, Campbell et al., 2004) and with longer duration of illness (McKinnon et al., 2009). Even though in vivo imaging studies document these significant reductions of volume, the exact
Acknowledgements
Christoph Anacker is currently funded by a studentship from the NIHR BRC. Carmine M. Pariante has been funded by the UK MRC since 1999, first as a Clinical Training Fellow, and currently as an MRC Clinician Scientist Fellow. His research is also funded by the NIHR South London and Maudsley NHS Foundation Trust & Institute of Psychiatry Specialist Biomedical Research Centre for Mental Health, the NARSAD, the APIRE, the British Academy and the European Union Framework 7. Livia Carvalho is funded
References (110)
- et al.
Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders
Prog Neurobiol
(2008) Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age
Front Neuroendocrinol
(1993)- et al.
Social interactions, stress, and immunity
Immunol Allergy Clin North Am.
(2009) - et al.
Cytokines and psychopathology: lessons from interferon-alpha
Biol Psychiatry
(2004) - et al.
Depressive symptoms are associated with elevated serum proinflammatory cytokines among pregnant women
Brain Behav Immun
(2009) - et al.
Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression
Neuron
(2009) - et al.
A meta-analysis of cytokines in major depression
Biol Psychiatry
(2010) Depression: a case of neuronal life and death?
Biol Psychiatry
(2004)- et al.
Interleukin-1 receptor type 1-deficient mice fail to develop social stress-associated glucocorticoid resistance in the spleen
Psychoneuroendocrinology
(2008) - et al.
Dexamethasone induces neurodegeneration but also up-regulates vascular endothelial growth factor A in neonatal rat brains
Neuroscience
(2009)
Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide
Brain Behav Immun
Corticosteroids in the prevention and management of bronchopulmonary dysplasia
Semin Neonatol
Emerging role of glutamate in the pathophysiology of major depressive disorder
Brain Res Rev.
The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity
Neuroscience.
Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression
Psychiatry Res
Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement
J Affect Disord
Chronic stress: implications for neuronal morphology, function and neurogenesis
Front Neuroendocrinol
Depressed new neurons—adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression
Biol Psychiatry
Depression following pegylated interferon-alpha: characteristics and vulnerability
J Psychosom Res
Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: implications for depression and antidepressant action
Eur Neuropsychopharmacol
Evidence for a cytokine model of cognitive function
Neurosci Biobehav Rev
The diurnal variation of plasma cortisol levels in depression
J Psychosom Res
Glucocorticoids, depression, and mood disorders: structural remodeling in the brain
Metabolism
Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression
Biol Psychiatry
A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling
Biol Psychiatry
Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment
Schizophr Res
Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression
Med Hypotheses
Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression
Brain Behav Immun
The HPA axis in major depression: classical theories and new developments
Trends Neurosci
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Biol Psychiatry
Pro-inflammatory cytokines and their effects in the dentate gyrus
Prog Brain Res
Cytokines sing the blues: inflammation and the pathogenesis of depression
Trends Immunol
Is impaired neurogenesis relevant to the affective symptoms of depression?
Biol Psychiatry
Neuroimaging studies of mood disorder effects on the brain
Biol Psychiatry
The macrophage theory of depression
Med Hypotheses
Cellular changes in the postmortem hippocampus in major depression
Biol Psychiatry
Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal
Biol Psychiatry
Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder
J Psychiatry Neurosci
Influence of continuous infusion of interleukin-1beta on depression-related processes in mice: corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression
Psychopharmacology (Berl)
Conceptual challenges of a tentative model of stress-induced depression
PLoS ONE
Cognitive therapy of depression
Increase in concentration of waking salivary cortisol in recovered patients with depression
Am J Psychiatry
Increased salivary cortisol after waking in depression
Psychopharmacology (Berl)
Antidepressants increase neural progenitor cells in the human hippocampus
Neuropsychopharmacology
Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment
Mol Psychiatry
Lower hippocampal volume in patients suffering from depression: a meta-analysis
Am J Psychiatry
Adrenal cortical activity in depressive illness
Am J Psychiatry
Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression
Neuropsychopharmacology.
In vitro modulation of the glucocorticoid receptor by antidepressants
Stress
Monoamine dysfunction and the pathophysiology and treatment of depression
J Clin Psychiatry
Cited by (433)
Diurnal cortisol, neuroinflammation, and neuroimaging visual rating scales in memory clinic patients
2024, Brain, Behavior, and ImmunityDose-dependent action of cordycepin on the microbiome-gut-brain-adipose axis in mice exposed to stress
2023, Biomedicine and Pharmacotherapy